Sacheerome

Which are the latest news on Sacheerome?

Why is Sacheerome Ltd falling/rising?

As of 05-Sep, Sacheerome Ltd's stock price is rising to 485.25, reflecting a 6.54% increase. The stock has outperformed the Sensex over various periods, showing strong returns and trading above moving averages, despite a decrease in investor participation.

As of 05-Sep, Sacheerome Ltd's stock price is rising, currently at 485.25, with a change of 29.8, reflecting an increase of 6.54%. This upward movement is supported by the stock's strong performance relative to the benchmark Sensex, where Sacheerome has outperformed over various periods, including a 6.50% increase over the past week compared to a decline of 1.15% in the Sensex. Additionally, the stock has shown impressive returns of 16.77% over the past month and a remarkable 152.73% increase over the past year, while the Sensex has experienced a decline of 2.91% and 3.38%, respectively.<BR><BR>Today's performance indicates that Sacheerome is outperforming its sector by 6.27%. Furthermore, the stock is trading above its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically suggests a bullish trend. However, it is important to note that there has been a decrease in investor participation, with delivery volume falling by 42.13% against the 5-day average. Despite this decline in participation, the stock remains liquid enough for trading, indicating that there is still sufficient interest in the stock.<BR><BR>Overall, the combination of strong relative performance, positive returns over multiple time frames, and trading above moving averages contributes to the rising stock price of Sacheerome Ltd.

What does Sacheerome do?

Sacheerome Ltd is a micro-cap company in the specialty chemicals industry with a market cap of INR 1,000 Cr. It has no recent sales or profit reports, a P/E ratio of 35, and a return on equity of 19.16%.

Overview:<BR>Sacheerome Ltd operates in the specialty chemicals industry and is categorized as a micro-cap company.<BR><BR>History:<BR>Details regarding the incorporation year and any status changes are not available. There are no sales and profit reports for the latest quarter.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 1,000 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 35.00<BR>Industry P/E: 43<BR>Dividend Yield: 0.00%<BR>Debt-Equity: -0.30<BR>Return on Equity: 19.16%<BR>Price-to-Book: 6.87<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Who are the peers of the Sacheerome?

Peers of Sacheerome include Oriental Aromatics, Nitta Gelatin, Excel Industries, and others. Sacheerome shows excellent growth and management risk, with a 1-year return of 120.36%, significantly outperforming its peers.

Peers: The peers of Sacheerome are Oriental Aromat., Nitta Gelatin, Excel Industries, Platinum Industr, Gem Aromatics, Jyoti Resins, Sunshield Chem., Sudarshan Pharma, and Amal.<BR><BR>Quality Snapshot: Excellent management risk is observed at Nitta Gelatin, Jyoti Resins, and the rest have Average management risk. Growth is Excellent at Sacheerome and Sudarshan Pharma, Good at Jyoti Resins, while Below Average growth is found at Oriental Aromat., Excel Industries, Platinum Industr, Sunshield Chem., and Gem Aromatics. Capital Structure is Excellent at Nitta Gelatin, Excel Industries, Platinum Industr, and Jyoti Resins, while Below Average is noted at Gem Aromatics and Sudarshan Pharma, with the rest having Average capital structure.<BR><BR>Return Snapshot: Sacheerome has the highest 1-year return at 120.36%, while Gem Aromatics has the lowest at -39.07%. Compared to its peers, Sacheerome's return is significantly higher. Additionally, the six-month return is negative for Gem Aromatics and Sudarshan Pharma.

How has been the historical performance of Sacheerome?

Sacheerome has shown consistent growth from March 2023 to March 2025, with net sales increasing from 70.49 Cr to 107.54 Cr and profit after tax rising from 5.99 Cr to 15.98 Cr, indicating strong operational efficiency and profitability. Total assets and shareholder's funds also grew significantly, reflecting a solid financial foundation.

Answer:<BR>The historical performance of Sacheerome shows a consistent growth trend across various financial metrics from March 2023 to March 2025.<BR><BR>Breakdown:<BR>Sacheerome's net sales increased from 70.49 Cr in March 2023 to 107.54 Cr in March 2025, reflecting a strong upward trajectory. Total operating income followed suit, rising from 70.49 Cr to 107.54 Cr during the same period. The company's total expenditure also grew, from 60.57 Cr in March 2023 to 85.12 Cr in March 2025, driven by rising raw material costs and other expenses. Operating profit, excluding other income, improved significantly from 9.92 Cr to 22.42 Cr, indicating enhanced operational efficiency. Profit before tax surged from 8.34 Cr to 21.42 Cr, and profit after tax rose from 5.99 Cr to 15.98 Cr, demonstrating robust profitability growth. The earnings per share (EPS) increased from 14.68 to 9.79, while the PAT margin improved from 8.5% to 14.86%. On the balance sheet, total assets grew from 47.89 Cr to 83.27 Cr, and shareholder's funds increased from 35.34 Cr to 61.99 Cr, indicating a solid financial foundation. The cash flow from operating activities also showed improvement, rising from 9.00 Cr to 22.00 Cr, while net cash inflow reached 1.00 Cr by March 2025. Overall, Sacheerome's financial performance reflects significant growth and strengthening of its financial position over the observed period.

Is Sacheerome overvalued or undervalued?

As of September 17, 2025, Sacheerome is considered "very expensive" and overvalued with a PE Ratio of 33.32, an EV to EBITDA of 23.35, and a Price to Book Value of 8.59, indicating high valuation relative to earnings and assets, despite outperforming the Sensex recently.

As of 17 September 2025, Sacheerome has moved from a grade of "does not qualify" to "very expensive." The company is currently overvalued based on its financial metrics. Key ratios include a PE Ratio of 33.32, an EV to EBITDA of 23.35, and a Price to Book Value of 8.59, all of which suggest a high valuation relative to earnings and assets.<BR><BR>In comparison to its peers, Sacheerome's valuation stands out, particularly against Solar Industries with a PE of 106.01 and Godrej Industries at 40.66. This indicates that while Sacheerome is expensive, it is not the highest in its sector. Additionally, despite its recent stock performance showing a 24.52% return over the past week compared to a 1.43% return of the Sensex, the overall valuation metrics suggest that Sacheerome is not justified at its current price level.

How big is Sacheerome?

As of 25th March, Sacheerome Ltd does not have a market capitalization value available and lacks financial data for the latest four quarters. The latest balance sheet shows Shareholder's Funds at 61.99 Cr and Total Assets at 83.27 Cr as of March 2025.

As of 25th March, Sacheerome Ltd does not have a market capitalization value available, therefore it cannot be classified into any market cap type.<BR><BR>There is no valid financial data available for the latest four quarters, so Net Sales and Net Profit figures cannot be provided.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds reported at 61.99 Cr and Total Assets at 83.27 Cr.

Who are the top shareholders of the Sacheerome?

The top shareholder of Sacheerome is Manoj Arora, who holds 51.18%. Other notable shareholders include Bharat Venture Opportunities Fund at 2.19%, individual investors with 12.55%, and 35 foreign institutional investors holding a total of 1.46%.

The top shareholders of Sacheerome include the promoters, with Manoj Arora holding the highest stake at 51.18%. There are no pledged promoter holdings. In terms of public shareholders, Bharat Venture Opportunities Fund is the largest, holding 2.19%. Additionally, individual investors collectively hold 12.55%, and the company has 35 foreign institutional investors (FIIs) with a combined holding of 1.46%.